# Dominion Energy, Inc: financial statements, quarterly

D · NYSE · CIK 715957 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/d.md) · [Financials](/companies/d/financials.md) · [Filings](/companies/d/filings.md) · [Insiders](/companies/d/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/d/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,080](/filings/0000950170-24-089020.md) | [3,758](/filings/0000950170-24-119871.md) | [3,534](/filings/0000950170-25-028387.md) | [3,524](/filings/0000950170-25-061558.md) | [3,455](/filings/0000950170-25-101177.md) | [3,785](/filings/0001193125-25-260246.md) | [3,400](/filings/0001193125-26-063120.md) | [4,085](/filings/0001193125-26-200275.md) | [3,718](/filings/0000950170-25-101177.md) | [4,510](/filings/0001193125-25-260246.md) | [4,093](/filings/0001193125-26-063120.md) | [5,091](/filings/0001193125-26-200275.md) |
| Operating income | $m | [594](/filings/0000950170-25-028387.md) | [1,029](/filings/0000950170-25-028387.md) | [712](/filings/0000950170-25-028387.md) | [833](/filings/0001193125-26-063120.md) | [805](/filings/0001193125-26-063120.md) | [1,218](/filings/0001193125-26-063120.md) | [391](/filings/0001193125-26-063120.md) | [1,223](/filings/0001193125-26-200275.md) | [1,096](/filings/0001193125-26-063120.md) | [1,339](/filings/0001193125-26-063120.md) | [756](/filings/0001193125-26-063120.md) | [1,392](/filings/0001193125-26-200275.md) |
| Income tax | $m | [98.0](/filings/0000950170-24-089020.md) | [195](/filings/0000950170-24-119871.md) | [175 d](/filings/0001193125-26-063120.md) | [55.0](/filings/0000950170-25-061558.md) | [112](/filings/0000950170-25-101177.md) | [213](/filings/0001193125-25-260246.md) | [(10.0) d](/filings/0001193125-26-063120.md) | [40.0](/filings/0001193125-26-200275.md) | [220](/filings/0000950170-25-101177.md) | [216](/filings/0001193125-25-260246.md) | [56.0 d](/filings/0001193125-26-063120.md) | [48.0](/filings/0001193125-26-200275.md) |
| Net income | $m | [575](/filings/0000950170-25-028387.md) | [153](/filings/0000950170-25-028387.md) | [331](/filings/0000950170-25-028387.md) | [403](/filings/0001193125-26-063120.md) | [563](/filings/0001193125-26-063120.md) | [934](/filings/0001193125-26-063120.md) | [134](/filings/0001193125-26-063120.md) | [665](/filings/0001193125-26-200275.md) | [760](/filings/0001193125-26-063120.md) | [1,006](/filings/0001193125-26-063120.md) | [567](/filings/0001193125-26-063120.md) | [621](/filings/0001193125-26-200275.md) |
| Diluted EPS | $ per share | [0.66](/filings/0000950170-25-028387.md) | [0.16](/filings/0000950170-25-028387.md) | [0.37](/filings/0000950170-25-028387.md) | [0.46](/filings/0001193125-26-063120.md) | [0.64](/filings/0001193125-26-063120.md) | [1.09](/filings/0001193125-26-063120.md) | [0.14](/filings/0001193125-26-063120.md) | [0.77](/filings/0001193125-26-200275.md) | [0.88](/filings/0001193125-26-063120.md) | [1.16](/filings/0001193125-26-063120.md) | [0.65](/filings/0001193125-26-063120.md) | [0.69](/filings/0001193125-26-200275.md) |
| Basic EPS | $ per share | [0.66](/filings/0000950170-25-028387.md) | [0.16](/filings/0000950170-25-028387.md) | [0.37](/filings/0000950170-25-028387.md) | [0.46](/filings/0001193125-26-063120.md) | [0.64](/filings/0001193125-26-063120.md) | [1.09](/filings/0001193125-26-063120.md) | [0.14](/filings/0001193125-26-063120.md) | [0.77](/filings/0001193125-26-200275.md) | [0.88](/filings/0001193125-26-063120.md) | [1.17](/filings/0001193125-26-063120.md) | [0.65](/filings/0001193125-26-063120.md) | [0.69](/filings/0001193125-26-200275.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000950170-23-038380.md) | [0.1](/filings/0000950170-23-061178.md) | [0.2](/filings/0000950170-25-028387.md) | [0.3](/filings/0000950170-24-051708.md) | [0.1](/filings/0000950170-24-089020.md) | [1.8](/filings/0000950170-24-119871.md) | [0.3](/filings/0001193125-26-063120.md) | [0.4](/filings/0000950170-25-061558.md) | [0.3](/filings/0000950170-25-101177.md) | [0.9](/filings/0001193125-25-260246.md) | [0.3](/filings/0001193125-26-200275.md) | [0.4](/filings/0001193125-26-200275.md) |
| Current assets | $bn | [8.0](/filings/0000950170-23-038380.md) | [24.7](/filings/0000950170-23-061178.md) | [25.4](/filings/0000950170-25-028387.md) | [16.2](/filings/0000950170-24-051708.md) | [10.8](/filings/0000950170-24-089020.md) | [8.0](/filings/0000950170-24-119871.md) | [6.6](/filings/0001193125-26-063120.md) | [6.4](/filings/0000950170-25-061558.md) | [7.0](/filings/0000950170-25-101177.md) | [8.2](/filings/0001193125-25-260246.md) | [8.1](/filings/0001193125-26-200275.md) | [9.0](/filings/0001193125-26-200275.md) |
| Total assets | $bn | [106](/filings/0000950170-23-038380.md) | [106](/filings/0000950170-23-061178.md) | [109](/filings/0000950170-25-028387.md) | [102](/filings/0000950170-24-051708.md) | [100](/filings/0000950170-24-089020.md) | [99.8](/filings/0000950170-24-119871.md) | [102](/filings/0001193125-26-063120.md) | [105](/filings/0000950170-25-061558.md) | [107](/filings/0000950170-25-101177.md) | [112](/filings/0001193125-25-260246.md) | [116](/filings/0001193125-26-200275.md) | [119](/filings/0001193125-26-200275.md) |
| Current liabilities | $bn | [14.0](/filings/0000950170-23-038380.md) | [21.6](/filings/0000950170-23-061178.md) | [24.5](/filings/0000950170-25-028387.md) | [15.4](/filings/0000950170-24-051708.md) | [11.5](/filings/0000950170-24-089020.md) | [10.8](/filings/0000950170-24-119871.md) | [9.3](/filings/0001193125-26-063120.md) | [8.8](/filings/0000950170-25-061558.md) | [10.4](/filings/0000950170-25-101177.md) | [9.7](/filings/0001193125-25-260246.md) | [10.4](/filings/0001193125-26-200275.md) | [11.6](/filings/0001193125-26-200275.md) |
| Total liabilities | $bn | [77.6](/filings/0000950170-23-038380.md) | [77.9](/filings/0000950170-23-061178.md) | [81.5](/filings/0000950170-25-028387.md) | [74.6](/filings/0000950170-24-051708.md) | [73.3](/filings/0000950170-24-089020.md) | [72.3](/filings/0000950170-24-119871.md) | [72.6](/filings/0001193125-26-063120.md) | [73.8](/filings/0000950170-25-061558.md) | [76.6](/filings/0000950170-25-101177.md) | [79.9](/filings/0001193125-25-260246.md) | [82.4](/filings/0001193125-26-200275.md) | [84.9](/filings/0001193125-26-200275.md) |
| Long-term debt | $bn | not reported | not reported | [40.2](/filings/0000950170-24-019110.md) | not reported | not reported | not reported | [39.3](/filings/0000950170-25-028387.md) | not reported | not reported | not reported | [46.3](/filings/0001193125-26-063120.md) | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [4.6](/filings/0000950170-23-038380.md) | [3.8](/filings/0000950170-23-061178.md) | [4.0](/filings/0000950170-25-028387.md) | [3.6](/filings/0000950170-24-051708.md) | [3.2](/filings/0000950170-24-089020.md) | [4.1](/filings/0000950170-24-119871.md) | [2.5](/filings/0001193125-26-063120.md) | [2.1](/filings/0000950170-25-061558.md) | [3.8](/filings/0000950170-25-101177.md) | [2.5](/filings/0001193125-25-260246.md) | [2.5](/filings/0001193125-26-200275.md) | [3.1](/filings/0001193125-26-200275.md) |
| Shareholders' equity | $bn | [28.4](/filings/0000950170-23-038380.md) | [28.0](/filings/0000950170-23-061178.md) | [27.6](/filings/0000950170-25-028387.md) | [27.4](/filings/0000950170-24-051708.md) | [27.1](/filings/0000950170-24-089020.md) | [27.5](/filings/0000950170-24-119871.md) | [26.9](/filings/0001193125-26-063120.md) | [27.4](/filings/0000950170-25-061558.md) | [27.2](/filings/0000950170-25-101177.md) | [27.7](/filings/0001193125-25-260246.md) | [29.1](/filings/0001193125-26-200275.md) | [29.1](/filings/0001193125-26-200275.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,097 d](/filings/0000950170-24-089020.md) | [1,992 d](/filings/0000950170-24-119871.md) | [1,386 d](/filings/0001193125-26-063120.md) | [1,982](/filings/0000950170-25-061558.md) | [856 d](/filings/0000950170-25-101177.md) | [1,539 d](/filings/0001193125-25-260246.md) | [641 d](/filings/0001193125-26-063120.md) | [1,183](/filings/0001193125-26-200275.md) | [1,246 d](/filings/0000950170-25-101177.md) | [1,945 d](/filings/0001193125-25-260246.md) | [987 d](/filings/0001193125-26-063120.md) | [882](/filings/0001193125-26-200275.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [558 d](/filings/0000950170-24-089020.md) | [559 d](/filings/0000950170-24-119871.md) | [559 d](/filings/0001193125-26-063120.md) | [559](/filings/0000950170-25-061558.md) | [560 d](/filings/0000950170-25-101177.md) | [559 d](/filings/0001193125-25-260246.md) | [561 d](/filings/0001193125-26-063120.md) | [569](/filings/0001193125-26-200275.md) | [569 d](/filings/0000950170-25-101177.md) | [570 d](/filings/0001193125-25-260246.md) | [570 d](/filings/0001193125-26-063120.md) | [587](/filings/0001193125-26-200275.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [818](/filings/0000950170-23-038380.md) | [833](/filings/0000950170-23-061178.md) | [836](/filings/0000950170-24-051708.md) | [836](/filings/0000950170-24-089020.md) | [837](/filings/0000950170-24-119871.md) | [838](/filings/0000950170-25-061558.md) | [838](/filings/0000950170-25-101177.md) | [839](/filings/0001193125-25-260246.md) | [852](/filings/0001193125-26-200275.md) | [853](/filings/0000950170-25-101177.md) | [855](/filings/0001193125-25-260246.md) | [880](/filings/0001193125-26-200275.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 879,455,403 at 2026-04-24, from the cover of the [10-Q filed 2026-05-01](/filings/0001193125-26-200275.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.